Targeted Pulse: Social Determinants Link to Cervical Cancer, FDA News, and More
This week's Targeted Pulse focuses on the latest in cervical cancer, the FDA ODAC's vote for cilta-cel, and more.
Source: targetedonc.com
📰 Thoracic Malignancies Programme News
Thoracic Malignancies Programme News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thoracic Malignancies Programme. Real-time updates on events, politics, business and more.
Expert Insights on the United States Chemotherapy Shortage
Oncology experts discuss the platinum chemotherapy shortage in the United States.
Mayo Clinic In Rochester United States Dana Farber Cancer Institute New Haven Yale School Danielp Petrylak
Source: onclive.com
Experts Provide Key Perspectives on the US Cisplatin/Carboplatin Shortage
Experts from various institutions were interviewed by OncLive® at the 24th Annual International Lung Cancer Congress® about the ongoing platinum chemotherapy shortage in the United States.
Source: onclive.com
Further Research May Delineate Immunotherapy Resistance Mechanisms in Lung Cancer
Solange Peters, MD, PhD, discusses the successes and shortcomings of immunotherapy in patients with lung cancer; current challenges with defining resistance mechanisms to immunotherapy in this disease; and the potential applications of circulating tumor DNA monitoring in the early and metastatic disease settings.
Solange Peters Charles Swanton University Hospital Of Lausanne International Lung Cancer Congress Department Of Oncology Thoracic Malignancies Programme
Source: onclive.com
Dr Peters on Understanding Mechanisms of Resistance to Immunotherapy in NSCLC
Solange Peters, MD, PhD, discusses current understandings of mechanisms of resistance to immunotherapy in non–small cell lung cancer.
Solange Peters Department Of Oncology Thoracic Malignancies Programme University Hospital Of Lausanne Understanding Mechanisms Medical Oncology
Source: onclive.com